Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study (NCT06716554)
🩺 Plain-English Summary (8th-Grade Level)
This is a Multi-center, Multi-national, Prospective, Randomized, Double-Blind, Placebo- Controlled three arm study to evaluate the efficacy and safety of Shatavari for the treatment of Menopausal symptoms in Women. Participants will be randomized to either one of the three treatment arms.Participants will then be asked to either take one capsule containing Shatavari or Shatavari + Ashwagandha or Placebo orally once daily in the morning after breakfast with a glass of water for 8 weeks. All the subjects will be asked to continue their routine diet and physical activities during the whole study period. The primary objective is to compare the efficacy of shatavari for treatment of menopausal symptoms in women. The secondary objective is to compare the safety of shatavari for treatment of menopausal symptoms in women.
Who can join: Review the eligibility criteria below.
Location: SF Research Institute, Inc. — San Francisco, California
Age range: 45 Years to 55 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- SF Research Institute, Inc. — San Francisco, California
📞 Contact the Study Coordinator
Phone: (415) 690-9641
Email: khaleeqr.sfinstitute@gmail.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Menopause
- PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition — Tucson, Arizona
- Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study) — Aurora, Colorado
- Improving Functioning Among Aging Women Veterans — Baltimore, Maryland
- Transdermal Testosterone Gel for Female Sexual Interest and Arousal Disorder in Peri- and Post Menopause — Houston, Texas
- Health, Imaging, and Cognition Across the Menopausal Transition — Sherbrooke, Quebec
- A Study to Investigate the Effect of a Multivitamin, Multi-nutrient Supplement on Mental and Emotional Wellbeing — Chicago, Illinois
Explore by condition: All Menopause clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.